FDA Announces Biosimilar Funding Opportunity
LexBlog IP
MARCH 17, 2022
On March 7, 2022, the US Food and Drug Administration (FDA) issued a Funding Opportunity Announcement (FOA) to commit up to $5 million in fiscal year 2022 toward several research proposals. Specifically, the FDA anticipates awarding as many as five proposals up to $1 million in funding.
Let's personalize your content